India's Dr Lal Path Labs gains on considering issue of bonus shares
** Shares of Dr Lal Path Labs DLPA.NS climb 2.3% to 3,118.2 rupees ** Diagnostics firm to consider issuing bonus shares at a board meeting scheduled on October 31; it will also consider declaration of an interim dividend ** Stock on track to snap three straight sessions of losses ** DLPA rated "Buy" on avg, same as rival Metropolis Healthcare METP.NS - data compiled by LSEG ** YTD, DLPA up ~4% vs ~7% decline in METP (Reporting by Manvi Pant) ((Manvi.Pant@thomsonreuters.com; +918447554364;))
Recent news on Metropolis Healthcare
See all newsBrief: Metropolis Healthcare Q2fy27 Revenue Grew About 15% Year-On-Year
Brief: Metropolis Health Says Unit Metropolis Quality Solutions Enters Share Subscription And Shareholder's Agreements
Brief: Metropolis Health June-Quarter Consol Net Profit 566.7 Million Rupees
Brief: Metropolis Health Declares 2Nd Interim Dividend Of 1 Rupee Per Share
Brief: Metropolis Health March-Quarter Consol Net Profit 509 Million Rupees